CR1 genotype and haplotype involvement in coronary artery disease: The pivotal role of hypertension and dyslipidemia

  • Authors:
    • Chiara Boiocchi
    • Michele Zorzetto
    • Ilaria Sbarsi
    • Alessandro Pirotta
    • Sandra Schirinzi
    • Colomba Falcone
    • Mariaclara Cuccia
  • View Affiliations

  • Published online on: August 1, 2009     https://doi.org/10.3892/ijmm_00000221
  • Pages: 181-187
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Inflammation plays a pivotal role in the pathogenesis of atherosclerosis and coronary syndromes. Atherosclerosis is a complex multifactorial disorder. Data indicate that the complement proteins play a crucial role in the link between inflammation and atherogenesis. Thus, there is evidence supporting the role of complement activation in atherogenesis. Complement receptor 1 (CR1) is a membrane protein found on different cells involved in various activities of the complement system. We demonstrated the possible involvement of CR1 in atherosclerosis studying the allele and genotype frequencies of the CR1 Pro1827Arg, CR1 His1208Arg exon 22 and int27 HindIII polymorphisms in a sample of patients with angiographically documented coronary artery disease (CAD) (n=550) and in healthy controls (n=380) matched for age, gender and ethnicity. Our data showed no significant deviations between the two groups with regard to either allele or genotype frequencies. After stratification according to risk factors, our analysis revealed a reduced frequency of the GG genotype of the Pro1827Arg polymorphism in patients with CAD and dyslipidemia vs the controls (p=0.031) and of the GG and LL genotypes in CAD patients with dyslipidemia vs CAD patients without dyslipidemia regarding the Pro1827Arg and CR1 HindIII intron 27 polymorphisms (GG, p=0.019; LL, p=0,184). We analyzed the haplotype frequencies of CR1. A decrease in CAD patients carrying the CAC haplotype compared to controls (p=0.043) and a decrease in the CAC haplotype in CAD patients with hypertension vs healthy controls (p=0,029) were demonstrated. Our data showed a possible involvement of CR1 gene polymorphisms in the predisposition to the development of this disease.

Related Articles

Journal Cover

August 2009
Volume 24 Issue 2

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Boiocchi C, Zorzetto M, Sbarsi I, Pirotta A, Schirinzi S, Falcone C and Cuccia M: CR1 genotype and haplotype involvement in coronary artery disease: The pivotal role of hypertension and dyslipidemia. Int J Mol Med 24: 181-187, 2009
APA
Boiocchi, C., Zorzetto, M., Sbarsi, I., Pirotta, A., Schirinzi, S., Falcone, C., & Cuccia, M. (2009). CR1 genotype and haplotype involvement in coronary artery disease: The pivotal role of hypertension and dyslipidemia. International Journal of Molecular Medicine, 24, 181-187. https://doi.org/10.3892/ijmm_00000221
MLA
Boiocchi, C., Zorzetto, M., Sbarsi, I., Pirotta, A., Schirinzi, S., Falcone, C., Cuccia, M."CR1 genotype and haplotype involvement in coronary artery disease: The pivotal role of hypertension and dyslipidemia". International Journal of Molecular Medicine 24.2 (2009): 181-187.
Chicago
Boiocchi, C., Zorzetto, M., Sbarsi, I., Pirotta, A., Schirinzi, S., Falcone, C., Cuccia, M."CR1 genotype and haplotype involvement in coronary artery disease: The pivotal role of hypertension and dyslipidemia". International Journal of Molecular Medicine 24, no. 2 (2009): 181-187. https://doi.org/10.3892/ijmm_00000221